[Clinical Significance of Total Pancreatectomy for Multiple Pancreatic Metastases from Renal Cancer].
Gan To Kagaku Ryoho
; 48(13): 1957-1959, 2021 Dec.
Article
in Ja
| MEDLINE
| ID: mdl-35045459
ABSTRACT
With the progress of replacement therapy for pancreatic endocrine and exocrine functions, the indications for a total pancreatectomy are expanding, and reports of multiple pancreatic metastases of renal cancer are on the rise. In the present, we investigated the utility of a total pancreatectomy for multiple pancreatic metastases of renal cancer. The subjects were 8 patients who underwent a total pancreatectomy for multiple pancreatic metastases of renal cancer between 2012 and 2021. The median, postoperative observation period was 31(3-92)months. Six of 8 patients survived without cancer, and one survived with chemotherapy(pazopanib plus axitinib)plus radiation therapy(maintaining stable disease). The one, remaining patient died of hypoglycemia. Of the 8 patients, 4 survived for 2 years or more, and 2 survived for more than 5 years. Postoperative, support for endocrine and exocrine functions is indispensable, but a total pancreatectomy for multiple pancreatic metastases of renal cancer promises to be a viable treatment option owing to its favorable long-term prognosis.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Kidney Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
Ja
Journal:
Gan To Kagaku Ryoho
Year:
2021
Document type:
Article